BIOMAT Database Logo BIOMAT Database Logo

HIV antigenaemia and virus isolation from plasma during primary HIV infection. 1987

H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö

UI MeSH Term Description Entries
D008297 Male Males
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015488 HIV Antigens Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens. AIDS Antigens,HIV-Associated Antigens,HTLV-III Antigens,HTLV-III-LAV Antigens,LAV Antigens,Lymphadenopathy-Associated Antigens,T-Lymphotropic Virus Type III Antigens, Human,HIV Associated Antigens,HTLV III Antigens,HTLV III LAV Antigens,Lymphadenopathy Associated Antigens,T Lymphotropic Virus Type III Antigens, Human,Antigens, AIDS,Antigens, HIV,Antigens, HIV Associated,Antigens, HIV-Associated,Antigens, HTLV III,Antigens, HTLV-III,Antigens, HTLV-III-LAV,Antigens, LAV,Antigens, Lymphadenopathy Associated,Antigens, Lymphadenopathy-Associated,Associated Antigens, HIV,Associated Antigens, Lymphadenopathy,III Antigens, HTLV

Related Publications

H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
Modeling plasma virus concentration during primary HIV infection.
April 2000, Journal of theoretical biology,
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
Efficient isolation of HIV from plasma during different stages of HIV infection.
September 1988, Journal of medical virology,
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
HIV antigenaemia in acute HIV infection.
March 1987, Lancet (London, England),
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
Immunologic abnormalities related to antigenaemia during HIV-1 infection.
December 1988, Clinical and experimental immunology,
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
HIV dynamics in seminal plasma during primary HIV infection.
October 2008, AIDS research and human retroviruses,
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection.
January 2015, Journal of virus eradication,
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
HIV antigenaemia and prognosis.
November 1987, British medical journal (Clinical research ed.),
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads.
December 2010, Archives of virology,
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection.
July 1993, Journal of virological methods,
H Gaines, and J Albert, and M von Sydow, and A Sönnerborg, and F Chiodi, and A Ehrnst, and O Strannegård, and B Asjö
HIV isolation from plasma of HIV-infected persons.
June 1987, The New England journal of medicine,
Copied contents to your clipboard!